Additional information
Full Title | Multiple Sclerosis |
---|---|
Author(s) | Sandra Amor, Hans van Noort |
Edition | |
ISBN | 9780191649424, 9780199652570, 9780191649417 |
Publisher | OUP Oxford |
Format | PDF and EPUB |
Original price was: $18.99.$4.75Current price is: $4.75.
Access Multiple Sclerosis Now. Discount up to 90%
Full Title | Multiple Sclerosis |
---|---|
Author(s) | Sandra Amor, Hans van Noort |
Edition | |
ISBN | 9780191649424, 9780199652570, 9780191649417 |
Publisher | OUP Oxford |
Format | PDF and EPUB |
Multiple Sclerosis (MS) is thought to affect almost 2.5 million people worldwide. With the arrival of several new MS drugs and increased availability of information on the internet, many people are confronted by an overwhelming number of information sources about how best to manage their condition. This new book explains, in a clear and accessible way, what is currently known about MS. It provides an explanation of the disease process, symptoms, diagnosis, and how drugs and alternative approaches to disease management work. It also provides supplementary information on how lifestyle and diet changes may help. Multiple Sclerosis: The Facts addresses the most frequently asked questions about MS, and provides answers in an easy-to-read and accessible format. The book is an invaluable resource for people with MS, and their families and health care workers will also find it a go-to guide to help understand the disease more clearly. This book will also be of interest to medical students and MS researchers.
Original price was: $31.75.$9.53Current price is: $9.53.
Access Multiple Sclerosis Now. Discount up to 90%
Full Title | Multiple Sclerosis |
---|---|
Author(s) | Richard Spilsbury |
Edition | |
ISBN | 9781508182863, 9781508182832, 9781508140566 |
Publisher | Rosen Central |
Format | PDF and EPUB |
Multiple sclerosis, a progressive autoimmune disorder that affects the central nervous system, usually develops between the ages of twenty and fifty. This guide to multiple sclerosis describes the difference between the four types of the disease and how sufferers can manage their symptoms through medications such as corticosteroids. Though scientists are unsure what causes MS or how to prevent it from flaring up, readers will learn about new research into the genetic factors of the disease that could lead to new gene therapy treatments.
Original price was: $146.99.$24.99Current price is: $24.99.
Access Multiple Sclerosis Now. Discount up to 90%
Full Title | Multiple Sclerosis |
---|---|
Author(s) | Moses Rodriguez, Orhun H. Kantarci, Istvan Pirko |
Edition | |
ISBN | 9780199970193, 9780199740468 |
Publisher | Oxford University Press |
Format | PDF and EPUB |
This latest edition to the ‘Contemporary Neurology Series’ will fill one of the few remaining ‘neurologic gaps’ within the Series. ‘Multiple Sclerosis,’ written solely by Moses Rodriguez, Orhun Kantarci and Istvan Pirko of the Mayo Clinic in Rochester, MN will offer proven, effective treatments for specific presentations and symptoms of multiple sclerosis along with a pathophysiological explanation of why they work. It bridges a needed gap between overly simplistic therapy manuals and basic science texts that discuss human disease only insofar as it mimics what is observed in animal models of the disease in the laboratory. Additionally, it seeks to offer an efficient integrative approach to symptomatic treatment to avoid over-medication and side effects. It discusses the heterogeneous causes of the disease and the need to develop individualized treatments that address the basic pathophysiologic processes that characterize each patient’s disease with the future goal of individualized medicine.’Multiple Sclerosis’ covers both the basic research aspects of MS: epidemiology, neuropathology, genetics, and immunology as well as the treatment options associated with the MS patient: sleep, steroids, pharma, neuropsychology, and growth factors (to name a few). ‘Multiple Sclerosis’ will focus on the medical treatment – drug treatment – of MS rather than on physical medicine and rehabilitation (not the author’s strength). The authors will also make ample use of flow diagrams, bulleted points, and tables to help the reader better understand MS and its etiology and treatment.
Original price was: $11.99.$3.00Current price is: $3.00.
Access Multiple Sclerosis Now. Discount up to 90%
Full Title | Multiple Sclerosis |
---|---|
Author(s) | Gary Birnbaum |
Edition | |
ISBN | 9780199748419, 9780195373165 |
Publisher | Oxford University Press |
Format | PDF and EPUB |
Multiple Sclerosis (MS) is an inflammatory, often progressive, and potentially disabling disease of the central nervous system. Onset of the disease is usually between the ages of 15 and 50, with the incidence nearly twice as high in women. While the cause of MS is still unknown, the predominant theory is that it is an autoimmune disease, triggered by an unknown environmental factor that results in both loss of central nervous system myelin and degeneration of axons and neurons. Although there have been a number of publications addressing different aspects of MS treatment in the neurological literature, there is a dearth of material on MS designed for internists and primary care physicians, who are often the first to see patients presenting symptons of MS. Therefore, this concise, clinically focused volume will serve as a valuable resource tailored to the specific needs of internists and primary care physicians. Part of the Oxford Neurology Library, this highly practical pocketbook covers current approaches and new developments in the diagnosis, treatment, and management of MS, including both early and advanced stages of the disease. The book offers in-depth coverage of special populations, as well as the more unusual manifestations of MS, which are less familiar to the internal medicine audience. It will also address the role of imaging studies in the diagnosis, differential diagnosis and monitoring of the progression of MS. In addition to providing up-to-date information on pharmacological therapies for MS, the book also describes an array of non-pharmacological treatment options.